A study for a 14 year old boy who takes Cotempla Xr-Odt - from FDA reports


2,737 males aged 14 (±5) who take the same drug are studied. This is a personalized study for a 14 year old male patient who has Adhd. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Aug, 18, 2018

2,737 males aged 14 (±5) who take Cotempla Xr-Odt are studied.


Number of reports submitted per year:

Cotempla Xr-Odt for a 14-year old boy.

Information of the patient in this study:

  • Age: 14
  • Gender: male
  • Conditions: Adhd
  • Drugs taken:
    • Cotempla Xr-Odt (methylphenidate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Drug ineffective
  2. Application site erythema (redness of the skin at application site)
  3. Abnormal behavior
  4. Nausea (feeling of having an urge to vomit)
  5. Application site urticaria
1 - 6 months:
  1. Application site erythema (redness of the skin at application site)
  2. Drug ineffective
  3. Drug administration error
  4. Application site rash
  5. Application site vesicles (small bubble within a cell at application site)
6 - 12 months:
  1. Application site erythema (redness of the skin at application site)
  2. Drug ineffective
  3. Application site pruritus (application site severe itching of the skin)
  4. Disturbance in attention
  5. Vitiligo (pigment is lost from areas of the skin)
1 - 2 years:
  1. Drug ineffective
  2. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  3. Disturbance in attention
  4. Disturbance in social behavior
  5. Application site erythema (redness of the skin at application site)
2 - 5 years:
  1. Disturbance in attention
  2. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  3. Drug ineffective
  4. Disturbance in social behavior
  5. Drug administration error
5 - 10 years:
  1. Disturbance in attention
  2. Psychomotor hyperactivity (feelings of extreme restlessness)
  3. Overdose
  4. Drug effect decreased
  5. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
10+ years:
  1. Irritability
  2. Heart rate increased
  3. Thirst
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
not specified:
  1. Drug administration error
  2. Drug ineffective
  3. Application site erythema (redness of the skin at application site)
  4. Application site pruritus (application site severe itching of the skin)
  5. Disturbance in attention

Top conditions involved for these people *:

  1. Stress And Anxiety : 58 people, 2.12%
  2. Hypersensitivity : 40 people, 1.46%
  3. Insomnia (sleeplessness): 33 people, 1.21%
  4. Asthma : 30 people, 1.10%
  5. Sleep Disorder : 25 people, 0.91%

Top co-used drugs for these people *:

  1. Intuniv (81 people, 2.96%)
  2. Ritalin (57 people, 2.08%)
  3. Focalin (48 people, 1.75%)
  4. Clonidine (46 people, 1.68%)
  5. Risperdal (45 people, 1.64%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.